Fig. 1From: Serum level of hepcidin in cirrhotic patients as a marker for hepatocellular carcinomaROC curve involving hepcidin (ng/ml) and serum AFP (ng/ml) to distinguish group II (patients with both cirrhosis and HCC) (n = 30) away from group I (cirrhotic patients diagnosed with no HCC) (n = 30)Back to article page